All News

Altered peptides from a South American wasp’s venom can kill bacteria but are nontoxic to human cells.

Nutritional, biotech, medical devices, personal care products and, more broadly, the entire pharmaceutical industry are the focus Pharmintech Exhibition, taking place in Bologna (Italy) from 10 to 12 April 2019.  The main aim of...

Company now able to serialise commercial batches manufactured by them for clients; it can also offer standalone serialisation services as an outsourcing partner.

Gandhi Automation’s Prime Clean Reset doors was selected when a major food and beverage manufacturer was tasked with effectively separating several key operations rooms in its facility to improve sanitation and material handling. Initially, the aes...

The global pharmaceutical industries will continuously grow in developing biologic drugs. Global pharmaceutical companies will allocate more resources to develop innovative drugs, cutting-edge med-tech, and precise medical treatment. In addition, mo...

The financing will power the global commercial launch of the company's Fluidity One system.

Main drivers cited as ‘high-growth domestic market’ and ‘expanding manufacturing exports’.

The new treatment will leverage OnDosis’ proprietary technology, which integrates oral drugs in form of micro units and individualised dosing, in a handheld device.

Closing of sale to Procter & Gamble at a cash purchase price of €3.4 billion completed.

Zenith Technology survey reveals that more than half of those surveyed believe that Industry 4.0 will drive the most change.

The gel formulation includes the progestin compound segesterone acetate, in combination with testosterone, and is applied to the back and shoulders and absorbed through the skin.

Company provided with exclusive rights to market a suite of Hansoh's injectable oncology medicines within the US for the next 5 years.

Expansion supports the growing needs of the company's pharmaceutical, biotechnology and CRO partners.

Subsidiary Kingchem Laboratories Inc. established

Cobra Biologics, Pall, and the Cell and Gene Therapy Catapult share £1.5 million grant from the UK's innovation agency.

Products containing Erdosteine from Recipharm are now marketed in over 40 countries across the world and is available in four different dosage forms.

Commissioned with immense pride NEW additional GREENFIELD Manufacturing facility at JHAGADIA, Bharuch, Gujarat  India.

Patients could receive faster treatment following boost to streamline the production of medicines and treatments.

Extra funding for strategic move into downstream formulation and fill finish capabilities and full exploitation of Lock-Release as new ADC manufacturing paradigm.

Company has successfully developed and validated impurity test methods in line with ICH Q3D regulatory guidelines.

Sartorius Stedim Biotech will continue to offer Lonza media and buffer products but under a non-exclusive agreement.

Wax-based and readily biodegradable: Euperlan OP White and Cegesoft Peel.

Event sees more innovation centralising at the Paris hub with entries for the awards and Start-up Hub opening.

Companies that have left it too late to implement their own solution will have to rely on support from providers, whose resources are already in high demand as the deadline approaches.

Trainees are provided with real-world examples of process workflows.

Larger headquarters will enable the company to free up space for additional laboratories and further expand capabilities.

Accreditation ensures quality and integrity of non-clinical laboratory studies to support pharmaceutical and biotech industries.

Company's manufacturing building for laboratory instruments in Göttingen wins the Global Excellence in Operations Award.

The absolute bioavailability of the Valtoco intranasal formulation was 96% of intravenous diazepam in a Phase I cross-over trial.

BioProduction’s content platform will be added to the bioLIVE exhibition, creating one of the world’s largest event hubs for the bio industry.

Despite Brexit looming, the company's EU & UK business has increased by almost 30% in the last 12 months.

Company will focus on robust biosimilar portfolio for unmet access and sustainability needs.

Th company's CombiCult combinatorial cell culture technology will be used to generate high fidelity, progenitor and terminally differentiated neuronal and glial cell subtypes for incorporation into next-generation models.

November 1, 2018, San Ramon, CA – Today, rfxcel, the leader in track and trace solutions for global supply chains celebrates its 15th business anniversary. 

Acquisition further strengthens Lonza’s commitment to drive the next generation of manufacturing patient-specific and personalized therapies.

With only a month to go, it really is too late to start trying to develop an in-house solution.

OPTi-OX technology allows the company to produce human cells of unprecedented quality, purity, and consistency.

Restriction due to potential cross-contamination.

Eight of the top ten pharma nations reporting improving market conditions.

CF3 coupled with UV-Vis detection able to separate and quantify the amount of free drug in a liposome-drug product.

‘One Site Shop’ expands to respond to growing demands.

BioVyon range have been incorporated into products to achieve more sensitive analysis, better healthcare, improved medical knowledge and faster diagnosis and treatment of diseases.

The new ‘Centre of Excellence’ already boasts one of the world’s most advanced gummy production line designed to meet demand from global markets.

The virtual platform is designed to allow the healthcare industry to effectively research and explore new technologies that will help to shape the future of the pharmaceutical supply chain.

State of the art facility to develop and manufacture High Potent cytotoxic drugs. New unit for High potent APIs and intermediates (HPAPI), fully integrated on PROCOS site with dedicated facilities from R&D to cGMP production.

Mylan achieves key milestone to provide US diabetes patients with more affordable generic version of Sanofi's Lantus insulin glargine vials.

New facility will offer customers the full range of services from development through to commercial-scale manufacturing

Accepting more complexity and risk is key for those generics companies seeking competitive differentiation by diversifying their product portfolios.

CMOs hit by reduced volumes of opioid manufacturing from DEA quota changes, but cannabis sales to ignite.

Ajinomoto Althea and OmniChem, global leaders in large and small molecule contract manufacturing, announced that they are integrating as a unified CDMO and operating as Ajinomoto Bio-Pharma Services

17 winners chosen from over 250 entries, with Nanobiotix winning both ‘CEO‘ and ‘Pharma Company of the Year’ categories.

One study uses the company's proprietary TurChub model, to evaluate the diffusion and subsequent activity of drugs in human nails.

Therapeutic ADC market expected to reach $4 billion by 2023.

The MG2 Tekna increases the CDMO’s manufacturing capacity to up to 500 million capsules per year.

Strengthens the CDMO's position as a centre of excellence as part of the viral vector drug development supply chain.

Meet Avivia / Excipia at booth 3A100  CPHI Madrid 2018

August 2, 2018: Abdi Ibrahim, the Turkish pharmaceutical industry leader, has carefully selected rfxcel to implement and support new compliance management and serialisation processing software to ensure full compliance with current and f...

Partnership aims to increase the robustness and reduce costs for the manufacturing of AAV vectors.

WHEATON® COMPLETEPAK is a range of primary packaging components supplied sterile ready-to-use from a single source. The crimp top vials, stoppers and seals in each kit have batch specific certificates of analysis that document compliance with rele...

Samsung BioLogics was established in April 2011, and is headquartered in Incheon, South Korea. Samsung BioLogics provides an end-to-end service for contracted biopharmaceutical production from cell-line development, process development, and commercial ...

Companies new to CPHI to showcase an exciting range of products and services ranging from electroceuticals to refrigerant alternatives.

Greater product protection thanks to reliable sealing technologies.

The PODs ease verification, qualification and validation challenges, and their flexibility allows them to support multiple products.

Idifarma's GMP spray drying technology for highly potent drugs up to Category 4 OEL/OEB is now operational.

Smaller bioreactors and high-density perfusion techniques needed as manufacturing makes significant efficiency improvements.

Facility to focus on developing and manufacturing the company's biosimilar portfolio.

Best-in-class facility enhances capacity to scale production of highly potent ingredients for customers demanding small to full GMP batches

Encorafenib in combination with binimetinib demonstrated 14.9 months median progression-free survival compared with vemurafenib monotherapy (7.3 months).

Lonza expansion includes drug substance development, and drug substance and drug product manufacturing.

GARDair removes the need for animal testing and opens a completely new market.

Provides single source of expertise for scaled production of complex biologics for gene therapy and vaccines.

While not quite an endangered species, the past fifteen years have not been easy ones for many European mould makers. Many, but not all, and IGS GeboJagema is a case in point – a case that shows the difference automation and focus can make. By Karen La...

Dr. Paul Lohmann GmbH KG is the world’s leading manufacturer of high value mineral salts for the pharmaceutical, biopharmaceutical, nutritional supplement and food industry. Since 1886, a high level of flexibility and an innovative spirit enables Dr. P...

The new Primary Care and China & Emerging Markets global business units are expected to launch at the beginning of 2019.

The Xelum R&D offers pharmaceutical manufacturers an ideal start to continuous OSD production.

Connection allows the marketing authorisation holders within the Recipharm Group to continue to supply medicines to patients post the EU FMD implementation date.

China is harmonizing to ICH standards at feverish pace and will force poor quality manufacturers out of market.

Pall and Aetos to advance the market impact of biosimilars and deliver lower-priced, high-quality options to end users.

Fruquintinib - innovative medicine that has not previously been launched in China or internationally - provides a new therapeutic approach for metastatic colorectal cancer patients.

Swiss based toploading packaging specialist Dividella will show how its modular packaging solutions and services meet emerging pharma industry needs at the landmark CPHI Worldwide expo in Madrid on stand number 4D52

Dividella will ...

Zurich, 24 October 2017 – Today, VIO Chemicals has publicly launched its new branding and website, designed to emphasize the company’s competencies and aspirations and help widen its appeal and accessibility. The launch occurred at the CPHI Worldwi...

The new services will focus on quality control analysis and stability testing of biopharmaceuticals.

The Sandoz US portfolios to be sold to Aurobindo include approximately 300 products, as well as additional development projects.

Novel, dual-acting product revitalizes and protects skin against blue light and environmental aggressors around the clock.

Faster GMP incident response and resolution times when manufacturing IT applications fail or are not running to their optimum capacity.

Monomaterial packaging benefits Parenteral packaging specialist Dividella has long espoused the concept of using 100% monomaterials in its packaging solutions – not just for environmental reasons but also to deliver much lower  Total Cost...

With the purpose of enhancing the general storage capacities and improving internal logistics, we invested in the extension and modernization of existing manufacturing facilities. After the accomplishment of the construction works in ...

Behind everything that Alfasigma Contract Manufacturing does is a powerful driving force: passionate dedication to pharmaceutical manufacturing excellence to help guarantee the health and wellbeing of people everywhere.

Customers to benefit from simplified, scalable solutions for intensified cell culture.

Princeton, NJ – (August 21, 2018) Systech, a global technology leader in consumer safety, brand protection, and product authentication, along with representatives from leading healthcare industry companies and associations, came together to explore...

Company to use its combinatorial stem cell screening platform to develop technologies for the conversion of pluripotent stem cells into platelets.

US, Germany and Japan revealed as tier one nations in all categories with Sweden ranking the best of the rest.

Secure data sharing across the pharmaceutical industry.

PQE Group is proud to announce that the draft of the new Russian Guide for Industrial Data Integrity has been published on the website of GILS - Russian State Institute of Drugs and Good Practices.After the collaboration with C...

rfxcel, the leader in track and trace solutions for the pharmaceutical market, today announced tremendous growth in India. rfxcel more than doubled its annual sales performance in India and APAC. This speaks to the significant market opportunities...

With the deadline looming for enactment of EU FMD and US DSCSA, Vikash Pushpraj, SVP, rfxcel, explains how achieving compliance is about much more than technology. Companies not yet set up for serialisation will need to adopt best practices and leverag...

New facility to carry out EU release testing ensuring continuous supply for customers regardless of the outcome of Brexit negotiations.

Life Science Factory gGmbH offers labs, co-working spaces and consulting services for life science entrepreneurs.

A long list of data integrity warnings received by pharma companies have made them train their focus on building and fortifying their tracking mechanisms to prevent things from going wrong. One of the solutions is digitization and building a data repos...

SGS's expansion will enable the service provider to offer a full ICH Q6B physico-chemical characterization of biological products.

CPHI Annual Report expert sees CDMOs as potentially a source of process innovation but warns both regulator and license holders need to move past regulatory diktats.

Investment will triple Sharp’s clinical service capacity for the pharmaceutical, biotech and clinical research sectors.

Leading antibiotics manufacturer reduces unacceptable levels of production downtime.

C-CIT Sensors launches its innovative and easy-to-handle single-use wireless bi-parametric metabolic monitoring system.

Investment will fuel the digitalization of the global pharmaceutical supply chain through the integration of real-time information-sharing, to create a highly predictable supply chain for the industry.

With only 6 months left in which to become EU FMD-compliant, how can companies make the best use of their now limited options?

The company’s engagement in Corporate Social Responsibility includes reducing consumption of water in manufacturing by using innovative technologies.

CPHI Middle East & Africa opens in Abu Dhabi as finished dosage formulations expand quickly, driven by government reforms to further increase local manufacturing.

Company's multimillion pound purpose-built facility becomes fully operational amidst growing interest worldwide in its potentially game-changing plant transient expression technology, Hypertrans.

Now less than a year away from when the UK officially leaves the EU, the main goal remains the same - maintaining access to new drugs for patient health.

Tadalafil is indicated in the treatment of pulmonary arterial hypertension to improve exercise ability.

OULU, FINLAND - Admescope Ltd, a pre-clinical ADME-Tox service provider today announced the acquisition of MetaSafe AB, a company specialised in the field of metabolic biotransformation research.

New service to reliably and reproducibly isolate exosomes from almost any biofluid.

N.K. INDUSTRIES is the largest manufacturer of capping machine since 1978 . With demand of more accuracy we develope a wide range of pick and place type capping machine and with extream customer satisfaction we believe we are the best pick an...

Company moves away from manual processing in favour of automated, scalable platforms.

Company recognised for its innovation and continual delivery of new natural ingredients.

EU approves Novartis's Aimovig, a first-of-its-kind treatment specifically designed for migraine prevention.

Agreement includes Pall's next-generation Kaneka KanCapA 3G sorbent for the primary capture of mAbs from clarified cell culture.

The first non-radioactive, dual-tracer for sentinel lymph node biopsy approved in the US.